PMID: 7284679Apr 1, 1981

Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs

British Journal of Pharmacology
S J CokerI J Zeitlin


Acute coronary artery occlusion in anaesthetized open-chest greyhounds led to early release of thromboxane B2 (TxB2) into venous blood draining the ischaemic region. No release occurred from the remainder of the left ventricular wall (coronary sinus sampling). TxB2 release and ventricular ectopic activity were positively correlated (r = 0.863) 2 min post-occlusion. Aspirin (3 mg/kg i.v.) suppressed both local TxB2 release and ectopic activity and prevented ventricular fibrillation. It is suggested that TxB2 release is a factor contributing to early post-infarction arrhythmias.


May 1, 1988·Cardiovascular Drugs and Therapy·J R Parratt
May 1, 1985·Basic Research in Cardiology·S R JollyB R Lucchesi
Jan 1, 1992·European Journal of Clinical Pharmacology·R F BerntsenH Olsen
Nov 5, 1981·European Journal of Pharmacology·O Fagbemi, J R Parratt
Jan 1, 1990·Free Radical Biology & Medicine·M BernierD J Hearse
Apr 1, 1988·British Journal of Pharmacology·R M Tripathi, R Kaushal
Jan 11, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·A A ShehadehT J Regan
Mar 1, 1985·Basic Research in Cardiology·I Leprán, A M Lefer

Related Concepts

Cardiac Arrhythmia
Coronary Heart Disease
Canis familiaris
Thromboxane B2

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.